Skip to content
Back to SRRK

Scholar Rock Holding Corp

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 17, 2025
Transactions
44
Purchases
6
Sales
38
Purchase value
$12.00M
Sale value
$19.44M

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Srinivas AkkarajuDirector
4
Filed Oct 27, 2026Period of report Oct 23, 20260001253170-26-000014
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseOct 26, 2026
Common StockF6F348,988$41.59$2.04M6,380,517IndirectBy Samsara BioCapital, L.P.
PurchaseOct 26, 2026
Common StockF6F497,982$41.59$4.08M723,020IndirectBy Samsara Opportunity Fund, L.P.
PurchaseOct 23, 2026
Common StockF1F2F347,000$41.31$1.94M6,331,029IndirectBy Samsara BioCapital, L.P.
PurchaseOct 23, 2026
Common StockF1F494,000$41.31$3.88M624,038IndirectBy Samsara Opportunity Fund, L.P.
PurchaseOct 23, 2026
Common StockF5F3500$41.82$20.91K6,331,529IndirectBy Samsara BioCapital, L.P.
PurchaseOct 23, 2026
Common StockF5F41,000$41.82$41.82K625,038IndirectBy Samsara Opportunity Fund, L.P.
Filing footnotes · 6
  1. F1The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $40.77 to $41.75 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.
  2. F2The shares held by Samsara BioCapital LP ("Samsara LP") prior to the reported transaction reflect the disposition of 83,585 shares in which the Reporting Person had no pecuniary interest. The disposition of such shares by Samsara LP did not involve a change in the Reporting Person's beneficial ownership of such shares and, accordingly, was exempt from reporting under Section 16.
  3. F3Securities are directly held by Samsara LP. Samsara BioCapital GP, LLC ("Samsara LLC") is the general partner of Samsara LP and may be deemed to beneficially own the securities held by Samsara LP. The Reporting Person has voting and investment power over the securities held by Samsara LP and, accordingly, may be deemed to beneficially own the securities held by Samsara LP. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein.
  4. F4Securities are directly held by Samsara Opportunity Fund, L.P. ("Samsara Opportunity Fund"). Samsara Opportunity Fund GP, LLC ("Samsara Opportunity GP") is the general partner of Samsara Opportunity Fund and may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person has voting and investment power over the securities held by Samsara Opportunity Fund and, accordingly, may be deemed to beneficially own the securities held by Samsara Opportunity Fund. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein.
  5. F5The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $41.78 to $41.85 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.
  6. F6The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $41.15 to $41.93 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.
Open on SEC EDGAR
Jeffrey S. FlierDirector
4Rule 10b5-1 plan disclosed
Filed Jul 6, 2026Period of report Jul 1, 20260001193125-26-296252
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 1, 2026
Common StockF1F2F31,568$53.5328$83.94K29,341Direct
SaleJul 1, 2026
Common StockF1F4F51,470$54.2365$79.73K27,871Direct
SaleJul 1, 2026
Common StockF1F6F715$54.8757$823.1427,856Direct
Filing footnotes · 7
  1. F1This sale was effected pursuant to a Rule 10b-5-1 trading plan adopted on March 31, 2026 to cover tax obligations upon the vesting and settlement of restricted stock units (RSUs).
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.960 to $53.944, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  3. F3Consists of 22,502 shares of common stock and 6,839 RSUs.
  4. F4The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.950 to $54.800, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  5. F5Consists of 21,032 shares of common stock and 6,839 RSUs.
  6. F6The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.805 to $55.010, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  7. F7Consists of 21,017 shares of common stock and 6,839 RSUs.
Open on SEC EDGAR
Michael GilmanDirector
4Rule 10b5-1 plan disclosed
Filed Jul 6, 2026Period of report Jul 1, 20260001193125-26-296251
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 1, 2026
Common StockF1F2F31,346$53.544$72.07K60,709Direct
SaleJul 1, 2026
Common StockF1F4F51,155$54.2257$62.63K59,554Direct
SaleJul 1, 2026
Common StockF1F6F743$54.8145$2.36K59,511Direct
Filing footnotes · 7
  1. F1This sale was effected pursuant to a Rule 10b-5-1 trading plan adopted on March 31, 2026 to cover tax obligations upon the vesting and settlement of restricted stock units (RSUs).
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.970 to $53.955, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  3. F3Consists of 53,870 shares of common stock and 6,839 RSUs.
  4. F4The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.960 to $54.750, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  5. F5Consists of 52,715 shares of common stock and 6,839 RSUs.
  6. F6The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.790 to $55.010, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  7. F7Consists of 52,672 shares of common stock and 6,839 RSUs.
Open on SEC EDGAR
Kristina BurowDirector
4Rule 10b5-1 plan disclosed
Filed Jul 6, 2026Period of report Jul 1, 20260001193125-26-296248
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 1, 2026
Common StockF1F2F32,105$53.494$112.60K115,605Direct
SaleJul 1, 2026
Common StockF1F4F5948$54.2816$51.46K114,657Direct
Filing footnotes · 7
  1. F1This sale was effected pursuant to a Rule 10b-5-1 trading plan adopted on March 31, 2026 to cover tax obligations upon the vesting and settlement of restricted stock units (RSUs).
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.050 to $54.030, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  3. F3Consists of 108,766 shares of common stock and 6,839 RSUs.
  4. F4The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.040 to $54.795, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  5. F5Consists of 107,818 shares of common stock and 6,839 RSUs.
  6. F6The shares are held by ARCH Venture Fund VIII, L.P. ("ARCH VIII"). ARCH Venture Partners VIII, L.P. ("GPLP"), as the sole general partner of ARCH VIII, may be deemed to beneficially own the shares held by ARCH VIII. ARCH Venture Partners VIII, LLC ("GPLLC"), as the sole general partner of GPLP, may be deemed to beneficially own the shares held by GPLP. The GPLP and GPLLC disclaim beneficial ownership of such securities, except to the extent of any pecuniary interest therein.
  7. F7The managing directors of the GPLLC are Keith L. Crandell, Clinton Bybee and Robert Nelsen, and they may be deemed to beneficially own the shares held by ARCH VIII. Messrs. Crandell, Bybee and Nelsen disclaim beneficial ownership of such shares, except to the extent of any pecuniary interest therein. The Reporting Person is a managing director of the GPLP. The Reporting Person owns an interest in the GPLP but does not have voting or investment control over the shares held by ARCH VIII. The Reporting Person disclaims ownership of such shares, except to the extent of her pecuniary interest therein.
Open on SEC EDGAR
Joshua ReedDirector
4Rule 10b5-1 plan disclosed
Filed Jul 6, 2026Period of report Jul 1, 20260001193125-26-296247
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 1, 2026
Common StockF1F2F32,105$53.4958$112.61K20,466Direct
SaleJul 1, 2026
Common StockF1F4F5948$54.2814$51.46K19,518Direct
Filing footnotes · 5
  1. F1This sale was effected pursuant to a Rule 10b-5-1 trading plan adopted on March 21, 2026 to cover tax obligations upon the vesting and settlement of restricted stock units (RSUs).
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.050 to $54.030, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  3. F3Consists of 13,627 shares of common stock and 6,839 RSUs.
  4. F4The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.040 to $54.795, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  5. F5Consists of 12,679 shares of common stock and 6,839 RSUs.
Open on SEC EDGAR
Katie PengDirector
4Rule 10b5-1 plan disclosed
Filed Jul 6, 2026Period of report Jul 1, 20260001193125-26-296245
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 1, 2026
Common StockF1F2F32,988$53.5598$160.04K36,759Direct
SaleJul 1, 2026
Common StockF1F4F52,437$54.2526$132.21K34,322Direct
SaleJul 1, 2026
Common StockF1F6F721$54.9641$1.15K34,301Direct
Filing footnotes · 7
  1. F1This sale was effected pursuant to a Rule 10b-5-1 trading plan adopted on March 20, 2026 to cover tax obligations upon the vesting and settlement of restricted stock units (RSUs).
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.970 to $53.965, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  3. F3Consists of 23,958 shares of common stock and 12,801 RSUs.
  4. F4The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.967 to $54.815, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  5. F5Consists of 21,521 shares of common stock and 12,801 RSUs.
  6. F6The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.860 to $55.016, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  7. F7Consists of 21,500 shares of common stock and 12,801 RSUs.
Open on SEC EDGAR
Keith WoodsChief Operating Officer
4
Filed Apr 20, 2026Period of report Apr 16, 20260001104659-26-045584
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 16, 2026
Common StockF1F210,220$49.5745$506.65K620,055Direct
Filing footnotes · 2
  1. F1Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units ("RSUs") on April 15, 2026. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person. The shares vested pursuant to awards that were granted on April 27, 2025. Each RSU represents the contingent right to receive upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to these RSU awards vest annually over four years, subject to a continued service relationship with the Issuer on the applicable vesting date.
  2. F2Consists of 48,034 shares of common stock, 122,021 RSUs subject to time-based vesting conditions and 450,000 RSUs subject to performance- and time-based vesting conditions.
Open on SEC EDGAR
Akshay VaishnawDirector · President of R&D
4
Filed Apr 20, 2026Period of report Apr 16, 20260001104659-26-045583
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 16, 2026
Common StockF1F212,246$49.5745$607.09K630,542Direct
Filing footnotes · 2
  1. F1Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units ("RSUs") on April 15, 2026. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person. The shares vested pursuant to awards that were granted on April 27, 2025. Each RSU represents the contingent right to receive upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to these RSU awards vest annually over four years, subject to a continued service relationship with the Issuer on the applicable vesting date.
  2. F2Consists of 58,521 shares of common stock, 122,021 RSUs subject to time-based vesting conditions and 450,000 RSUs subject to performance- and time-based vesting conditions.
Open on SEC EDGAR
Vikas SinhaChief Financial Officer
4
Filed Apr 20, 2026Period of report Apr 16, 20260001104659-26-045582
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 16, 2026
Common StockF1F210,410$49.5745$516.07K619,856Direct
Filing footnotes · 2
  1. F1Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units ("RSUs") on April 15, 2026. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person. The shares vested pursuant to awards that were granted on April 27, 2025. Each RSU represents the contingent right to receive upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to these RSU awards vest annually over four years, subject to a continued service relationship with the Issuer on the applicable vesting date.
  2. F2Consists of 47,835 shares of common stock, 122,021 RSUs subject to time-based vesting conditions and 450,000 RSUs subject to performance- and time-based vesting conditions.
Open on SEC EDGAR
David HallalDirector · Chief Executive Officer
4
Filed Apr 20, 2026Period of report Apr 16, 20260001104659-26-045581
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 16, 2026
Common StockF1F230,615$49.5745$1.52M1,639,034Direct
Filing footnotes · 3
  1. F1Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units ("RSUs") on April 15, 2026. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person. The shares vested pursuant to awards that were granted on April 27, 2025. Each RSU represents the contingent right to receive upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to these RSU awards vest annually over four years, subject to a continued service relationship with the Issuer on the applicable vesting date.
  2. F2Consists of 198,530 shares of common stock, 315,504 RSUs subject to time-based vesting conditions and 1,125,000 RSUs subject to performance- and time-based vesting conditions.
  3. F3Shares owned by the Hallal Family Irrevocable Trust - 2012 dated November 19, 2012 (the "Hallal Trust") for no consideration. The reporting person's spouse serves as a trustee of the Hallal Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Open on SEC EDGAR
Mo QatananiCHIEF SCIENTIFIC OFFICER
4Rule 10b5-1 plan disclosed
Filed Feb 25, 2026Period of report Feb 23, 20260001104659-26-019789
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 23, 2026
Common StockF1F2F37,427$46.9422$348.64K99,502Direct
SaleFeb 23, 2026
Common StockF1F4F5857$47.8588$41.01K98,645Direct
SaleFeb 23, 2026
Common StockF1F6F7200$48.48$9.70K98,445Direct
Filing footnotes · 7
  1. F1This transaction was effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2025.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.52 to $47.48, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  3. F3Consists of 1,057 shares of common stock and 98,445 RSUs.
  4. F4The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $47.55 to $48.19, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  5. F5Consists of 200 shares of common stock and 98,445 RSUs.
  6. F6The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $48.30 to $48.66, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  7. F7Consists of 98,445 RSUs.
Open on SEC EDGAR
Mo QatananiCHIEF SCIENTIFIC OFFICER
4
Filed Feb 19, 2026Period of report Feb 17, 20260001980298-26-000009
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 17, 2026
Common StockF1F27,989$46.5282$371.71K106,929Direct
Filing footnotes · 2
  1. F1Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the vesting of restricted stock units ("RSU") on February 15, 2026. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person. The shares vested pursuant to awards that were granted on February 13, 2023 and March 10, 2025. Each RSU represents the contingent right to receive upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to these RSU awards vest annually over four years, subject to a continued service relationship with the Issuer on the applicable vesting date.
  2. F2Consists of 8,484 shares of common stock and 98,445 RSUs.
Open on SEC EDGAR
Caryn ParlavecchioCHRO
4
Filed Feb 19, 2026Period of report Feb 17, 20260001922346-26-000004
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 17, 2026
Common StockF1F29,035$46.5282$420.38K169,087Direct
Filing footnotes · 2
  1. F1Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the vesting of restricted stock units ("RSU") on February 15, 2026. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person. The shares vested pursuant to awards that were granted on February 13, 2023 and March 10, 2025. Each RSU represents the contingent right to receive upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to these RSU awards vest annually over four years, subject to a continued service relationship with the Issuer on the applicable vesting date.
  2. F2(2) Consists of 86,859 shares of common stock and 82,228 RSUs.
Open on SEC EDGAR
Junlin HoGENERAL COUNSEL
4
Filed Feb 19, 2026Period of report Feb 17, 20260001868114-26-000004
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 17, 2026
Common StockF1F29,580$46.5282$445.74K241,545Direct
Filing footnotes · 2
  1. F1Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the vesting of restricted stock units ("RSU") on February 15, 2026. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person. The shares vested pursuant to awards that were granted on February 13, 2023 and March 10, 2025. Each RSU represents the contingent right to receive upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to these RSU awards vest annually over four years, subject to a continued service relationship with the Issuer on the applicable vesting date.
  2. F2Consists of 131,646 shares of common stock and 109,899 RSUs.
Open on SEC EDGAR
Jing L. MarantzCHIEF MEDICAL OFFICER
4
Filed Feb 19, 2026Period of report Feb 17, 20260001834528-26-000005
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleFeb 17, 2026
Common StockF1F24,157$46.5282$193.42K126,012Direct
Filing footnotes · 2
  1. F1Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the vesting of restricted stock units ("RSU") on February 15, 2026. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person. The shares vested pursuant to awards that were granted on February 13, 2023 and March 10, 2025. Each RSU represents the contingent right to receive upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to these RSU awards vest annually over four years, subject to a continued service relationship with the Issuer on the applicable vesting date.
  2. F2Consists of 29,388 shares of common stock and 96,624 RSUs.
Open on SEC EDGAR
Mo QatananiCHIEF SCIENTIFIC OFFICER
4Rule 10b5-1 plan disclosed
Filed Jan 23, 2026Period of report Jan 22, 20260001980298-26-000007
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 22, 2026
Common StockF1F2F32,119$45.8655$97.19K98,439Direct
SaleJan 22, 2026
Common StockF1F4F512,779$46.8541$598.75K85,660Direct
Filing footnotes · 5
  1. F1This transaction was effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2025.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.43 to $46.42, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  3. F3Consists of 12,779 shares of common stock and 85,660 RSUs.
  4. F4The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.43 to $47.31, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  5. F5Consists of 85,660 RSUs.
Open on SEC EDGAR
Mo QatananiCHIEF SCIENTIFIC OFFICER
4
Filed Jan 21, 2026Period of report Jan 16, 20260001980298-26-000004
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 16, 2026
Common StockF1F28,406$44.4777$373.88K100,558Direct
Filing footnotes · 2
  1. F1Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the vesting of restricted stock units ("RSU") on January 15, 2026. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person. The shares vested pursuant to awards that were granted on February 14, 2022 and February 12, 2024. Each RSU represents the contingent right to receive upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to these RSU awards are fully vested.
  2. F2Consists of 14,898 shares of common stock and 85,660 RSUs.
Open on SEC EDGAR
Caryn ParlavecchioCHRO
4
Filed Jan 21, 2026Period of report Jan 16, 20260001922346-26-000002
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 16, 2026
Common StockF1F26,600$44.4777$293.55K148,864Direct
Filing footnotes · 2
  1. F1Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the vesting of restricted stock units ("RSU") on January 15, 2026. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person. The shares vested pursuant to awards that were granted on February 14, 2022 and February 12, 2024. Each RSU represents the contingent right to receive upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to these RSU awards are fully vested.
  2. F2Consists of 78,283 shares of common stock and 70,581 RSUs.
Open on SEC EDGAR
Junlin HoGENERAL COUNSEL
4
Filed Jan 21, 2026Period of report Jan 16, 20260001868114-26-000002
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 16, 2026
Common StockF1F28,016$44.4777$356.53K214,553Direct
Filing footnotes · 2
  1. F1Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the vesting of restricted stock units ("RSU") on January 15, 2026. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person. The shares vested pursuant to awards that were granted on February 14, 2022 and February 12, 2024. Each RSU represents the contingent right to receive upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to these RSU awards are fully vested.
  2. F2Consists of 121,471 shares of common stock and 93,082 RSUs.
Open on SEC EDGAR
Jing L. MarantzCHIEF MEDICAL OFFICER
4
Filed Jan 21, 2026Period of report Jan 16, 20260001834528-26-000003
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 16, 2026
Common StockF1F25,798$44.4777$257.88K95,687Direct
Filing footnotes · 2
  1. F1Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the vesting of restricted stock units ("RSU") on January 15, 2026. This sale is mandated by the Issuer's election under its equity incentive plans to require the Reporting Person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person. The shares vested pursuant to awards that were granted on February 12, 2024. Each RSU represents the contingent right to receive upon vesting of the RSU, one share of the Issuer's common stock. The shares subject to these RSU awards are fully vested.
  2. F2Consists of 24,974 shares of common stock and 70,713 RSUs.
Open on SEC EDGAR
Mo QatananiCHIEF SCIENTIFIC OFFICER
4Rule 10b5-1 plan disclosed
Filed Jan 16, 2026Period of report Jan 14, 20260001980298-26-000002
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 14, 2026
Common StockF1F7F813,112$45.1961$592.61K108,964Direct
Filing footnotes · 13
  1. F1This transaction was effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2025.
  2. F10961 shares remain unvested under this stock option. The first vesting event occurred on January 5, 2023 and the remainder vests in fifteen quarterly installments thereafter; provided the reporting person continues to have a service relationship with the Issuer on such vesting date.
  3. F1111,250 shares remain unvested under this stock option. The first vesting event occurred on April 1, 2023 and the remainder vests in fifteen quarterly installments thereafter; provided the reporting person continues to have a service relationship with the Issuer on such vesting date.
  4. F1247,143 shares remain unvested under this stock option. The first vesting event occurred on April 1, 2024 and the remainder vests in fifteen quarterly installments thereafter; provided the reporting person continues to have a service relationship with the Issuer on such vesting date.
  5. F1332,142 shares remain unvested under this stock option. The first vesting event occurred on April 1, 2025 and the remainder vests in fifteen quarterly installments thereafter; provided the reporting person continues to have a service relationship with the Issuer on such vesting date.
  6. F2Consists of 1,407 shares of common stock and 108,964 RSUs.
  7. F3Consists of 1,728 shares of common stock and 108,964 RSUs.
  8. F4Consists of 4,541 shares of common stock and 108,964 RSUs.
  9. F5Consists of 10,434 shares of common stock and 108,964 RSUs.
  10. F6Consists of 13,112 shares of common stock and 108,964 RSUs.
  11. F7The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.45, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  12. F8Consists of 108,964 RSUs.
  13. F9No shares remain unvested under this stock option.
Open on SEC EDGAR
Vikas SinhaChief Financial Officer
4
Filed Jan 15, 2026Period of report Jan 13, 20260001104659-26-004224
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 13, 2026
Common StockF1F2F316,755$42.70$715.44K583,245Direct
Filing footnotes · 3
  1. F1Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the vesting of restricted stock units subject to performance-and time-based vesting conditions ("PSUs"). The sale is mandated by the Issuer's election under its equity incentive plans to require the Reporting Person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person. Each PSU represents the contingent right to receive upon vesting of the PSU, one share of the Issuer's common stock.
  2. F2(continued) The shares vested pursuant to awards that were granted on April 27, 2025. 50,000 shares subject to this PSU vested on January 12, 2026, with an additional 50,000 shares scheduled to vest on April 27, 2027 and the remaining shares vesting in tranches of a combination of performance-based vesting tied to the Issuer's common stock achieving certain price targets and time-based vesting over four year, provided the Reporting Person continues to have a service relationship with the Issuer on each such vesting date. Any PSUs that have not vested on or prior to April 27, 2029 will be forfeited for no consideration.
  3. F333,245 shares of common stock, 100,000 restricted stock units and 450,000 PSUs.
Open on SEC EDGAR
Keith WoodsChief Operating Officer
4
Filed Jan 15, 2026Period of report Jan 13, 20260001104659-26-004223
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 13, 2026
Common StockF1F2F316,746$42.70$715.05K583,254Direct
Filing footnotes · 3
  1. F1Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units subject to performance- and time-based vesting conditions ("PSUs"). This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person. Each PSU represents the contingent right to receive upon vesting of the PSU, one share of the Issuer's common stock.
  2. F2(continued) The shares vested pursuant to awards that were granted on April 27, 2025. 50,000 shares subject to this PSU vested on January 12, 2026, with an additional 50,000 shares scheduled to vest on April 27, 2027 and the remaining shares vesting in tranches of a combination of performance-based vesting tied to the Issuer's common stock achieving certain price targets and time-based vesting over four years, provided the reporting person continues to have a service relationship with the Issuer on each such vesting date. Any PSUs that have not vested on or prior to April 27, 2029 will be forfeited for no consideration.
  3. F3Consists of 33,254 shares of common stock, 100,000 restricted stock units subject to time-based vesting conditions and 450,000 PSUs.
Open on SEC EDGAR
Akshay VaishnawDirector · President of R&D
4
Filed Jan 15, 2026Period of report Jan 13, 20260001104659-26-004222
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 13, 2026
Common StockF1F2F320,438$42.70$872.70K595,767Direct
Filing footnotes · 3
  1. F1Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the vesting of restricted stock units subject to performance-and time-based vesting conditions ("PSUs"). The sale is mandated by the Issuer's election under its equity incentive plans to require the Reporting Person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person. Each PSU represents the contingent right to receive upon vesting of the PSU, one share of the Issuer's common stock.
  2. F2(continued) The shares vested pursuant to awards that were granted on April 27, 2025. 50,000 shares subject to this PSU vested on January 12, 2026, with an additional 50,000 shares scheduled to vest on April 27, 2027 and the remaining shares vesting in tranches of a combination of performance-based vesting tied to the Issuer's common stock achieving certain price targets and time-based vesting over four year, provided the reporting person continues to have a service relationship with the Issuer on each such vesting date. Any PSUs that have not vested on or prior to April 27, 2029 will be forfeited for no consideration.
  3. F345,767 shares of common stock, 100,000 restricted stock units and 450,000 PSUs.
Open on SEC EDGAR
David HallalDirector · Chief Executive Officer
4
Filed Jan 15, 2026Period of report Jan 13, 20260001104659-26-004221
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJan 13, 2026
Common StockF1F2F357,450$42.70$2.45M1,541,645Direct
Filing footnotes · 4
  1. F1Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the vesting of restricted stock units subject to performance-and time-based vesting conditions ("PSUs"). The sale is mandated by the Issuer's election under its equity incentive plans to require the Reporting Person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person. Each PSU represents the contingent right to receive upon vesting of the PSU, one share of the Issuer's common stock.
  2. F2(continued) The shares vested pursuant to awards that were granted on April 27, 2025. 125,000 shares subject to this PSU vested on January 12, 2026, with an additional 125,000 shares scheduled to vest on April 27, 2027 and the remaining shares vesting in tranches of a combination of performance-based vesting tied to the Issuer's common stock achieving certain price targets and time-based vesting over four year, provided the Reporting Person continues to have a service relationship with the Issuer on each such vesting date. Any PSUs that have not vested on or prior to April 27, 2029 will be forfeited for no consideration.
  3. F3166,645 shares of common stock, 250,000 restricted stock units and 1,125,000 PSUs.
  4. F4Shares owned by the Hallal Family Irrevocable Trust - 2012 dated November 19, 2012 (the "Hallal Trust") for no consideration. The Reporting Person's spouse serves as a trustee of the Hallal Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Open on SEC EDGAR
Katie PengDirector
4Rule 10b5-1 plan disclosed
Filed Dec 18, 2025Period of report Dec 16, 20250001983850-25-000005
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 16, 2025
Common StockF1F2F3726$43.8761$31.85K33,188Direct
SaleDec 16, 2025
Common StockF1F4F5280$44.6344$12.50K32,908Direct
Filing footnotes · 5
  1. F1This sale was effected pursuant to a Rule 10b-5-1 trading plan adopted on November 20, 2024 to cover tax obligations upon the vesting and settlement of restricted stock units.
  2. F2The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.39 to $44.38, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  3. F3Consists of 15,124 shares of common stock and 18,064 RSUs.
  4. F4The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.39 to $45.23, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  5. F5Consists of 14,844 shares of common stock and 18,064 RSUs.
Open on SEC EDGAR
Mo QatananiCHIEF SCIENTIFIC OFFICER
4Rule 10b5-1 plan disclosed
Filed Dec 5, 2025Period of report Dec 4, 20250001980298-25-000007
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleDec 4, 2025
Common StockF1F9F10136,462$45.2125$6.17M108,964Direct
Filing footnotes · 15
  1. F1This transaction was effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2025.
  2. F10Consists of 108,964 RSUs.
  3. F111,282 shares remain unvested under this stock option. The first vesting event occurred on January 5, 2023 and the remainder vest in fifteen quarterly installments thereafter; provided the reporting person continues to have a service relationship with the Issuer on such vesting date.
  4. F121,407 shares remain unvested under this stock option. The first vesting event occurred on April 1, 2022 and the remainder vests in fifteen quarterly installments thereafter; provided the Reporting Person continues to have a service relationship with the Issuer on such vesting date.
  5. F1314,063 shares remain unvested under this stock option. The first vesting event occurred on April 1, 2023 and the remainder vests in fifteen quarterly installments thereafter; provided the Reporting Person continues to have a service relationship with the Issuer on such vesting date.
  6. F1453,036 shares remain unvested under this stock option. The first vesting event occurred on April 1, 2024 and the remainder vests in fifteen quarterly installments thereafter; provided the Reporting Person continues to have a service relationship with the Issuer on such vesting date.
  7. F1534,820 shares remain unvested under this stock option. The first vesting event occurred on April 1, 2025 and the remainder vests in fifteen quarterly installments thereafter; provided the Reporting Person continues to have a service relationship with the Issuer on such vesting date.
  8. F2Consists of 65,625 shares of common stock and 108,964 RSUs.
  9. F3Consists of 86,718 shares of common stock and 108,964 RSUs.
  10. F4Consists of 92,325 shares of common stock and 108,964 RSUs
  11. F5Consists of 93,606 shares of common stock and 108,964 RSUs.
  12. F6Consists of 104,856 shares of common stock and 108,964 RSUs.
  13. F7Consists of 128,427 shares of common stock and 108,964 RSUs.
  14. F8Consists of 136,462 shares of common stock and 108,964 RSUs.
  15. F9The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.00 to $45.46, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.